Idorsia

The purpose of Idorsia is to discover, develop and bring more, innovative medicines to patients

Launch date

Jan 2017

Employees

501-1000 people

Ownership

public, accelerator

Market cap

Net debt

CHF1.5b

Firm valuation

$3.9b (Public information from 2022)

Allschwil Canton of Basel-Landschaft (HQ)

http://idorsia.com

https://twitter.com/idorsia https://www.facebook.com/idorsia https://www.linkedin.com/company/idorsia/

Name

Market

Status